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Introduction: Behavioral variant frontotemporal dementia (bvFTD) shares clinical, 
cognitive and behavioral features with Alzheimer’s disease (AD), posing a challenge for 
differential diagnosis. Considering that disinhibition and impulsivity are hallmarks of 
bvFTD, cognitive and behavioural assessment of such symptoms may be useful for the 
differential diagnosis between bvFTD and AD. This study aimed to investigate the 
diagnostic value of neuropsychological tests of inhibitory control and behavioral 
measures of impulsivity and apathy to distinguish bvFTD from AD. 
Methods: Three groups of participants were enrolled: 27 bvFTD patients, 25 AD 
patients and 24 healthy controls. Groups were matched for gender, education and 
socioeconomic level. Participants underwent a comprehensive neuropsychological 
assessment, including tests of inhibitory control (Hayling Test, Stroop, the Five Digit 
Test [FDT] and the Delay Discounting Task [DDT]). Caregivers completed the Barratt 
Impulsivity Scale (BIS-11) and the Apathy Scale (AS). 
Results: Controls performed better than the clinical groups in most neuropsychological 
measures. There was no difference between bvFTD and AD for the cognitive measures 
of inhibitory control, including the DDT. Compared to AD, bvFTD patients were 
significantly more impulsive (BIS-11: bvFTD 76.1+9,5, AD 62.9+13, p<0.001) and 
more apathetic (AS: bvFTD 28.1+7,8, AD 16.9+9, p<0.001). 
Conclusions: Neuropsychological tests of inhibitory control failed to distinguish 
bvFTD from AD. On the contrary, apathy and impulsivity scales provided good 
distinction between bvFTD and AD. These results highlight the limits of cognitive 
measures of inhibitory control for the differential diagnosis between bvFTD and AD, 
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Behavioural variant frontotemporal dementia (bvFTD) shares clinical, cognitive and 
behavioural features with Alzheimer’s disease (AD), posing a challenge for differential 
diagnosis between these two disorders. In particular, disturbed executive functions that 
are classically found in bvFTD can also be impaired in AD, such as working memory, 
mental flexibility, and planning (Perry et al, 2000; Castiglioni, et al., 2006; Hornberger 
et al., 2010). However, among executive functions, tests of inhibitory control may be 
useful for the differential diagnosis between bvFTD and AD. Indeed, as disinhibition is 
a hallmark of bvFTD (Rascovsky et al, 2011), a comprehensive assessment of inhibitory 
control and impulsivity is potentially more accurate in identifying specific symptoms of 
bvFTD (O’Callaghan et al., 2013a). 
Inhibitory control refers to the ability to selectively supress thoughts or behaviours that 
are not adaptive or appropriate in the current context (Miyake et al., 2000; Diamond, 
2013). Impulsivity is broadly defined as acting prematurely without foresight (Dalley et 
al., 2011), and a specific sub-type of impulsivity refers to the tendency to prefer an 
immediate, but smaller, reward, rather than waiting for a larger, although delayed, 
reward (Rachlin, 2000; Kirby et al., 1991). 
The value of tasks of inhibitory control for the clinical diagnosis of bvFTD has been 
previously investigated. For instance, some authors reported that the Hayling test 
provides good clinical differentiation between bvFTD and AD (Torralva et al, 2009; 
Hornberger et al., 2010), although another study did not show a similar result (Flanagan 
et al, 2016). In contrast, the Stroop test, a classical measure of prepotent response 
inhibition, has poor diagnostic value in differentiating bvFTD and AD (Collete et al., 
2007; Perry et al, 2000). 
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More recent studies using tasks of delayed discounting tried to overcome the limits of 
classical inhibitory control tests. The Delay Discounting Task (DDT) requires the 
participant to make intertemporal choices, deciding between present vs. future reward 
options. This paradigm may be a reliable model for testing impulsivity (Ainslie, 1975; 
Odum, 2013). Some reports indicate that DDT can differentiate bvFTD from AD 
(Lebreton et al., 2013; Bertoux et al., 2015). 
One of the limits of neuropsychological tests used to investigate inhibitory functions is 
that they usually lack ecological validity and do not recapitulate real life situations. In 
the other hand, behavioural scales that tap into impulsivity are usually made of 
questions that investigate everyday situations. Therefore, it is possible that these 
behavioural scales might capture with better accuracy the disinhibition-related disorders 
associated to bvFTD.  
Taken together, there is some evidence that cognitive and behavioural assessment of 
impulsivity may facilitate the diagnosis of bvFTD. However, it is not clear whether 
cognitive tasks such DDT and Hayling are superior to behavioural scales in 
distinguishing bvFTD from AD. Indeed, previous studies (Lebreton et al, 2013; Bertoux 
et al, 2015) did not include behavioural scales to assess disinhibition. This is a critical 
point, as some reports showed that the measurement of impulsive behaviour can 
effectively differentiate bvFTD from AD (Paholpak et al., 2016; Grochmal-Bach et al., 
2009), while cognitive tests may fail to do so (Flanagan et al, 2016; Hornberger et al., 
2010; Collete et al., 2007; Perry et al, 2000). 
The present study aims to assess inhibitory control and impulsivity using 
neuropsychological and behavioural instruments, in order to determine the accuracy of 
these tools in the differential diagnosis between bvFTD and AD. As far as we know, 
this is the first time that the accuracy of the DDT and of other cognitive tests of 
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inhibitory control are simultaneously compared with a behavioural measure of 
impulsivity (Barratt Impulsivity Scale; Barratt et al., 1975; Malloy-Diniz, 2010). We 
further contrasted these tools with a measure of apathy (Apathy Scale; Starkstein, 2001; 
Guimarães et al. 2009), as quantitatively and qualitatively measures of apathy can also 
help in the distinction between AD and bvFTD (Fernandez-Matarrubia et al., 2017). 
Indeed, apathy and disinhibition may co-occur in bvFTD (Le Ber et al, 2006); both 
constitute the most prevalent neuropsychiatric disorders of bvFTD (Rascovski et al., 
2011). Then, carefully characterizing these two behavioural disorders could provide a 
diagnostic yield for bvFTD. 
 
METHODS 
Fifty- two patients were recruited in two Brazilian centres of Cognitive and Behavioural 
Neurology, located at Belo Horizonte (University Hospital from Universidade Federal 
de Minas Gerais) and São Paulo (University Hospital from Universidade de São Paulo). 
All of them fulfilled consensus diagnostic criteria for probable bvFTD (Rascovsky et 
al., 2011) or AD (McKhann et al., 2011). The AD group included patients at early and 
moderate stages of the disease. All bvFTD and AD patients underwent structural brain 
MRI. We did not include patients with neuroimaging disclosing focal lesions or severe 
vascular lesions. 
To improve diagnostic accuracy, patients were clinically followed for at least 18 months 
after the diagnostic definition and all of them showed clinical progression consistent 
with the diagnosis. 
A subset of patients (eight AD and eight bvFTD) underwent lumbar puncture for 
cerebrospinal fluid (CSF) biomarkers (Aß42, Tau and P-Tau) analyses. For this 
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subgroup, all AD patients had an “AD CSF biomarker profile”, defined by Tau/Aß42 > 
0.52 (Magalhães et al, 2015). None of the bvFTD patients had this biomarker profile. 
This procedure was adopted to increase the specificity of the clinical diagnosis. One 
bvFTD patient had a known genetic mutation (TARDBP). 
Community-dwelling elderly, with no history of neurologic or psychiatric disorders and 
intact cognitive assessment constituted the control group.  
Groups were matched for education level and socioeconomic status (Table 1). 
Socioeconomic level was controlled by the Brazilian standard classification (ABEP, 
2015). 
The local ethics committees approved the study (Project CAAE-17850513.2.0000.5149) 
and all participants gave written informed consent to participate. 
Cognitive Assessment 
All participants underwent the same cognitive protocol: Mini-Mental State Exam 
(MMSE) (Folstein et al., 1975; Brucki, 2003); Frontal Assessment Battery (FAB) 
(Dubois et al., 2000; Beato et al, 2012), Figure Memory Tests (FMT) (naming, 
incidental memory, immediate memory, learning, delay recall and recognition) from the 
Brief Cognitive Battery (Nitrini et al., 2004), verbal fluencies (‘FAS’ and ‘Animals’) 
(Machado et al., 2010), Forwards and Backwards Digit Span (Wechsler, 1997), Stroop-
Victoria (Spreen et al., 2006); Hayling (Burgess and Shallice, 1997; Siqueira et al., 
2010) and the Five Digits Test (FDT) (Sedó et al., 2015). 
Stroop Test is a classical paradigm designed to evaluate the capacity of suppress a 
prepotent answer in saying colours instead of reading it. Hayling Test evaluates the 
capacity to inhibit a prepotent verbal answer when completing phrases meaninglessly. 
FDT evaluates two major executive functions: inhibitory control, in a non-verbal Stroop 
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like condition, suppressing a prepotent answer in counting numbers rather than saying 
the stimuli, and cognitive flexibility, alternating two different rules in the same task. 
FDT was chosen because it is a non-verbal option to Stroop, and it avoids low-formal 
education effects (de Paula et al., 2011). 
Delay Discounting Task (DDT) 
The DDT was performed using a computerized version of the original questionnaire 
(Kirby et al., 1999), created using PowerPoint. Participants were required to choose 
either an amount of money available today or a larger amount available in the future. 
The amount of delay (days) and the sum of money varied. A total of 27 forced-choices 
were presented to participants one at a time, and delayed vs. immediate reward options 
were randomised to occur on either the left or right side of the screen in equal 
proportions. Figure 1 illustrates examples of two out the 27 forced-choices. Participants 
were not awarded any actual monetary payments based on their performance, but they 
were encouraged to approach the choices as if real money was at stake. 
A hyperbolic discount parameter (k) is inferred from subjects’ choices on the DDT. 
Delay discounting is the tendency to discount the present value of a reward as delay to 
the reward increases, calculated by the equation: PV = FV/(1 – kt), where: PV= Present 
Value; FV= Future Value; t= time; and, k= slope. A higher k value is consistent with a 
steeper discounting of future rewards, indicating a higher degree of impulsivity. 
The 27 options from DDT were comprised of nine items in three groups: small ($15 - 
$25), medium ($35 - $55) and large ($75 - $85) values, which refers to the size of the 
delayed reward. Thus, four parameters are extracted from DDT: a general k for all the 
27 items, and separate k values for small, medium and large items. Based on values 




Behaviour was assessed by the Apathy Scale (Starkstein et al., 2001; Guimarães et al, 
2009) and Barratt Impulsivity Scale 11th version (BIS-11) (Barratt et al., 1975; Malloy-
Diniz et al., 2010). 
Apathy Scale is formed by 14 items. The Brazilian version is already designed for third-
party reporting and presented good correlation with the apathy subscore from the 
Neuropsychiatric Inventory (Guimarães et al., 2009). 
BIS-11 is a self-report scale comprised by 30 items. The participant is required to 
analyse each item and classify the frequency of that behaviour, using a Likert scale. A 
higher score means a higher degree of impulsivity. The minimum score is 30 and the 
maximum is 120. In addition, three partial scores are obtained: motor impulsivity, 
attentional impulsivity and planning impulsivity (Malloy-Diniz et al., 2010). 
Similar to previous studies, the BIS-11 was adapted as a caregiver-report version, in 
order to avoid a possible anosognosia effect in the patients (O’Callaghan et al., 2013b). 
Controls completed the BIS-11 original version, but were not evaluated with the Apathy 
Scale. 
Patients were classified as “impaired” or “preserved” regarding their scores on Apathy 
Scale and BIS-11. For the Apathy Scale, a cut-off of 14 was established to determine 
impairment, considering that this value exceeds two standard-deviations (SD) from 
mean value in a healthy-population (Guimarães et al., 2014). For the BIS-11, a cut-off 
of 82 was established to determine impairment, as this value is 2 SD superior to the 





Descriptive and comparative analyses were performed. Normality was checked with 
Shapiro-Wilk test. Non-parametrical tests were chosen considering the majority of non-
normal distribution found in the different measures, except for behavioural scales, 
whose distributions were normal. For categorical variables chi-square was used. 
Kruskal-Wallis and Mann-Whitney pairwise post-hoc comparison were applied for 
continuous variables, except for behaviour, for which ANOVA with Bonferroni post-
hoc tests was applied. In the DDT, within group analyses were performed by the 
Wilcoxon method in order to evaluate magnitude effects. Receiver Operator 
Characteristics (ROC) curve analyses were carried out to test diagnostic accuracy. 
Analyses were performed with Statistical Package for the Social Sciences (SPSS) 22.0 
and MedCalc 17.1 softwares. 
 
RESULTS 
The final groups consisted of 27 bvFTD patients, 25 AD patients and 24 healthy 
controls. Table 1 describes sociodemographic data. bvFTD patients were significantly 
younger than AD; however, age did not differ between clinical groups and controls. 
Other sociodemographic variables (schooling and socioeconomic level) were similar 
across groups. AD and bvFTD patients had similar symptom duration. 
Considering neuropsychological measures, there were statistically significant 
differences between clinical groups and healthy controls, with bvFTD and AD scoring 
worse than controls on most measures (Table 1). There were no significant differences 
between bvFTD and AD for all measures of executive functions, apart from the 
“Flexibility” domain from the FDT, in which AD performed significantly worse than 
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bvFTD. AD patients also performed worse than bvFTD in the delayed recall from the 
Figure Memory Test.  
Regarding the DDT, there were no differences among groups for all parameters. The 
within group analyses, however, showed that the control group present k values for 
small rewards statistically higher than their k values for both the large and medium 
rewards. In contrast, for the bvFTD and AD groups, their k values for the small rewards 
were only significantly higher than their k values for the larges reward size. 
Both apathy and impulsivity measures revealed significant differences between the 
groups. bvFTD patients were more impulsive than both AD and controls, and were 
more apathetic than AD patients. Controls and AD did not differ in the impulsivity 
scale. Considering Brazilian norms for the BIS-11 (Malloy-Diniz et al., 2015), controls’ 
mean score was at the 45th percentile, AD scores were at the 55th percentile and bvFTD 
mean score were within the 90th – 95th percentile. 
The FDT Flexibility score, Apathy score and BIS-11 Total score were analysed in a 
ROC curve procedure to establish diagnostic accuracy of bvFTD versus AD (Table 3, 
Figure 2). For the Apathy scale, the cut-off of 19 provided 69.2% sensitivity and 92.6% 
specificity. The BIS-11 cut-off of 68 achieved 68.2% sensitivity and 80% specificity. 
FDT Flexibility achieved 86.4% sensitivity and 76.5% specificity with a cut-off of 54 
seconds. The composition of a unique score with all three or even two instruments did 
not improve the diagnostic accuracy significantly. 
Patients were classified as “impaired” or “preserved” according to their scores on the 
Apathy Scale and BIS-11 (Table 2). Only 2.4% of bvFTD patients had alteration neither 
on apathy nor on impulsivity, while 19.5% of AD patients had similar profile (with 
significant difference of frequencies between groups, p < 0.05). In the other hand, 
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19.5% of bvFTD patients had impairments on both apathy and impulsivity, while only 
4.5% of AD had similar pattern (p < 0.05). The two groups exhibited the same 
percentage of patients having apathy without impulsivity (no statistical difference). 
 
DISCUSSION 
This study investigated cognitive and behavioural markers of impulsivity for the 
differential diagnosis between bvFTD and AD. Behavioural scales (BIS-11 and Apathy 
Scale) provided better diagnostic accuracy than cognitive measures of inhibitory 
control, including the DDT, Stroop, and Hayling.  
Only one executive parameter (“flexibility” from FDT) was statistically different 
between bvFTD and AD. Neuropsychological tests of inhibitory control and impulsivity 
failed to distinguish between bvFTD and AD. Even though impulsivity is a clinical 
feature of bvFTD, previous studies assessing inhibitory control in bvFTD showed 
variable results. For instance, there are data showing either difference (Torralva et al, 
2009; Hornberger et al., 2010) or absence of difference between bvFTD and AD in the 
Hayling test of inhibition (Flanagan, 2016). In the present study, bvFTD and AD also 
did not differ in their performance on the Hayling test. Similarly, there was no 
difference in Stroop between patient groups, which is in agreement with previous 
observations showing that this test has poor association with behavioural and 
anatomical markers of inhibition (Heflin et al., 2011). 
The DDT also failed to detect differences between bvFTD and AD, in contrast to 
previous reports (Lebreton et al., 2013; Bertoux et al., 2015). The reasons for the 
present result remain unclear, but may be due to cultural specificities related to 
Brazilian background, such as political and economic instability and a history of 
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hyperinflation, especially in the 1980-1990s. Further studies are required to explore 
intercultural variability in DDT. 
Magnitude effect refers to the finding that discount rates decrease as the amount of 
reward increases, as subjects are more willing to wait for a larger reward (Green et al., 
2004). All groups exhibited magnitude effect on the DDT, showing largest k values for 
the smallest rewards. Nonetheless, AD and bvFTD patients’ differed only between large 
and small rewards, while controls had different scores between small rewards and both 
large and medium ones. This suggests that controls discounted small rewards more 
steeply compared to both of the larger rewards. This finding suggests that patients were 
less sensitive to magnitude effects, compared to controls.  
Apathy is the most common behavioural change in AD (Theleritis et al., 2014; 
Starkstein, 2001), and is also a core feature of bvFTD (Rascovsky et al, 2007). Our data 
confirms that apathy is frequent in both conditions. However, apathy is more severe in 
bvFTD than in AD patients, in accordance to previous reports (Lima-Silva et al., 2015; 
Liu et al, 2004; Chow, et al. 2009). 
There were significant differences between AD and bvFTD in the behavioural measure 
of impulsivity (BIS-11), which also achieved good accuracy for differential diagnosis, 
as revealed by ROC analysis. The BIS-11 may be a practical resource to distinguish 
bvFTD from AD (O’Callaghan et al., 2013b). Another point that may be useful for the 
differential diagnosis is that the association of apathy and impulsivity disorders is more 
frequent in bvFTD patients than in AD, with almost 20% of bvFTD cases achieving 
impaired levels on both scales, while only 4.5% of AD had similar profile.  
Taken together, our results highlight the limits of using cognitive measures of inhibitory 
control for the differential diagnosis between bvFTD and AD. Most tests of inhibitory 
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control were not specifically designed for neurodegenerative disorders. For instance, the 
DDT was initially developed to study addiction (Kirby et al., 1999), while the Stroop 
was originally designed for cognitive screening in young adults (Stroop, 1935).  
It is also important to consider that inhibitory control is a set of complex cognitive 
functions (Dalley et al., 2011; Munakata et al., 2011; Hampshire and Sharp, 2015). 
Indeed, distinct cognitive abilities are required for efficient inhibitory control. For 
instance, the DDT may engage diverse cognitive operations, such as prospective 
memory and emotional processing. Therefore, different cognitive deficits may underlie 
impulsive behaviour. bvFTD and AD patients may fail in tests of inhibitory control due 
to deficits in different sub-processes, which are not specifically tapped by most standard 
tests. Hence, the design of new tests of inhibitory control for the diagnosis of bvFTD 
should consider more specific sub-processes of this ability.   
The development of new cognitive tests for the diagnosis of bvFTD should also take 
into account the clinical variability of the disease (Whitwell et al, 2009; O’Connor et al, 
2017), with patients exhibiting either disinhibited, apathetic or mixed profiles (Le Ber et 
al, 2006; O’Connor et al, 2017). In our sample, 20% of bvFTD patients had mixed 
profile. The optimal cognitive diagnosis of bvFTD requires a set of tests tapping into the 
different possible behavioural aspects of the disease. 
This study presents some caveats. The diagnosis was established under clinical basis, 
and pathological confirmation was not available. However, patients were selected 
according to consensual criteria and all patients had a minimal follow-up of 18 months 
and had clinical progression consistent with the diagnosis. Apathy scale was not applied 
to controls, precluding comparative analyses with this group.   
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In conclusion, this study highlights the dissociation between cognitive tests of prefrontal 
functions and behavioural disorders related to these same regions, the “frontal paradox” 
(Mesulam, 1986; Burgess et al, 2009; Gleichgerrcht et al, 2010; Volle et al, 2012). The 
present study reinforces this observation, as bvFTD patients presented higher scores of 
impulsive behaviour than AD and controls, while no differences were observed in tasks 
tapping inhibitory control. There is a need to develop objective cognitive measures of 
disinhibited behaviour for clinical use. The gap between behaviour and cognition in 
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Male:Female 6:18 14:13 13:12 ns1 
Age (years), mean (SD) 70.8 (8.3) 67.8 (9.8) 74.6 (9.7)*  <0.05b3 
Education (years), mean (SD) 11.5 (3.8) 11.9 (3.6) 11.6 (5.3) ns2 
Disease duration (years), mean (SD) NA 4.1 (2.2) 2.9 (1.2) ns2 
Family income, mean (SD) 39.6 (12.1) 33.0 (10.3) 35.7 (11.8) ns2 
MMSE, mean (SD) 28.6 (1.3) 25.2 (3.5) 24.3 (2.8) <0.001a
3 
PDMT – delayed recall, mean (SD) NA 4.9 (2.5) 3.9 (2.2) <0.05b
3 
FAB, mean (SD) 14.7 (2.2) 12.6 (3.2) 12.96 (2.9) <0.001c
3 
Fluency (FAS), mean (SD) 34.7 (9.5) 23.5 (11.5) 26.5 (12.9) <0.05a
3 
Fluency (Animals), mean (SD) 17.2 (3.8) 10.5 (3.99) 10.60 (4.6) <0.05a
3 
Stroop Colour – time (sec.), mean (SD) 15.3 (1.8) 22. 4 (11.2) 25.3 (18.1) <0.01a
3 
Hayling Test     
- part A–time (sec.), mean (SD) 17.9 (5.4) 36.8 (33.7) 26.1 (8.6) <0.01a
3 
- part B–score (PQt), mean (SD) 9.7 (4.0) 6.96 (4.7) 5.5 (3.6) <0.05d
3 
- part B–scaled error (PQl), mean (SD) 10.2 (7.1) 18.2 (13.2) 17.4 (9.6) <0.05c
3 
Five Digits Test     
- switching – Time (sec.), mean (SD) 68.5 (15.3) 74.4 (23.1) 115.7 (50.7) <0.05bd
3 
- switching – Errors, mean (SD) 1.8 (2.9) 5.9 (6.2) 8.5 (8.7) ns
2 
- flexibility (sec.), mean (SD) 43.5 (13.7) 43.9 (18.7) 84.1 (45.1) <0.001bd
3 
Delayed Discounting Test     
- general k, mean (SD) 0.0722 (0.8907) 0.0531 (0.0856) 0.0580 (0.0696) ns
2 
- large k, mean (SD) 0.0619 (0.0914) 0.0563 (0.0917) 0.0546 (0.0730) ns
2 
- medium k, mean (SD) 0.0774 (0.0891) 0.0626 (0.0961) 0.0673 (0.0905) ns
2 
- small k, mean (SD) 0.0974 (0.0988) 0.0662 (0.0873) 0.0884 (0.0893) ns
2 
Apathy score, mean (SD) NA 28.1 (7.8) 16.9 (9) <0.05b
4 
Barrat Impulsivity Scale – 11th     
- total score, mean (SD) 59.4 (8.1) 76.1 (9.5) 62.9 (13.5) <0.05bc
6 
- motor score, mean (SD) 19.7 (2.96) 22.7 (5.9) 20.1 (4.8) ns
5 
- attention score, mean (SD) 15.1 (3.0) 18.8 (3.3) 14.9 (4.7) <0.05bc
6 
- planning score, mean (SD) 24.6 (4.3) 34.7 (4.3) 27.9 (7.1) <0.05bc
6 
Analyses: a:Controls≠ others; b:AD ≠ bvFTD; c:Controls ≠ bvFTD; d: Controls ≠ AD 
Tests: 1: Chi-square; 2: Kruskal-Wallis; 3: Mann-Whitney; 4:t-test Student; 5: ANOVA; 6: Bonferroni post-
hoc test. 
In bold, measurements which differed statistically between dementia groups, and between one dementia group 
(either AD or bvFTD ) and controls (Apathy Scale was not applied to controls). 
AD: Alzheimer’s disease; bvFTD: behavioural variant frontotemporal dementia ; MMSE: Mini-Mental State 
Examination ; FAB: Frontal Assessment Battery ; FAS: Phonemic fluency test ; PDMT: picture drawings 
















% of cases 11.1% 88.9% 100.0% 
0.011 
Expected 48.9% 51.1% 100.0% 
% from total 2.4% 19.5% 21.9% 
Apathy: + 
BIS-11: - 
% of cases 50.0% 50.0% 100.0% 
Expected 48.6% 51.4% 100.0% 
% from total 26.8% 26.8% 53.6% 
Apathy: + 
BIS-11: + 
% of cases 80.0% 20.0% 100.0% 
Expected 49.0% 51.0% 100.0% 





Table 1: Results for Receiver Operator Characteristics (ROC) Curve analysis  
Instrument 







BIS-11 Total score 0.788 0.0713 0.634 a 0.898 0.001 
Apathy Total score 0.828 0.0616 0.695 a 0.920 <0.0001 
Flexibility-FDT 0.832 0.0671 0.677 a 0.932 <0.001 
 
BIS-11: Barratt Impulsivity Scale 11th version 








































Figure 2 - Title: Receiver Operator Characteristics (ROC) Curve for Apathy, Barratt 
Impulsivity Scale (BIS-11) and Five Digit Test - Flexibility 
 
 
 
 
 
 
 
 
 
 
 
 
